Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helminthiasis | 11 | 2019 | 81 | 2.170 |
Why?
|
| Anthelmintics | 12 | 2019 | 83 | 1.450 |
Why?
|
| Pregnancy Complications, Parasitic | 9 | 2017 | 61 | 1.450 |
Why?
|
| Albendazole | 9 | 2019 | 50 | 0.920 |
Why?
|
| Helminths | 3 | 2018 | 39 | 0.880 |
Why?
|
| Uganda | 20 | 2021 | 1332 | 0.800 |
Why?
|
| Hypersensitivity | 6 | 2021 | 1171 | 0.760 |
Why?
|
| Hookworm Infections | 4 | 2019 | 17 | 0.740 |
Why?
|
| Praziquantel | 6 | 2017 | 34 | 0.680 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2020 | 125 | 0.670 |
Why?
|
| Allergens | 6 | 2021 | 1432 | 0.660 |
Why?
|
| Dermatitis, Atopic | 3 | 2020 | 731 | 0.660 |
Why?
|
| Population Dynamics | 1 | 2020 | 307 | 0.620 |
Why?
|
| Urban Population | 4 | 2021 | 2036 | 0.620 |
Why?
|
| Eczema | 4 | 2014 | 246 | 0.520 |
Why?
|
| Schistosomiasis mansoni | 4 | 2023 | 93 | 0.480 |
Why?
|
| Skin Tests | 5 | 2021 | 637 | 0.440 |
Why?
|
| Asthma | 7 | 2023 | 6234 | 0.440 |
Why?
|
| Immunoglobulin E | 7 | 2021 | 1502 | 0.420 |
Why?
|
| Schistosomiasis | 2 | 2023 | 65 | 0.370 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2017 | 347 | 0.360 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2017 | 2518 | 0.290 |
Why?
|
| Air Pollutants | 1 | 2019 | 2896 | 0.250 |
Why?
|
| Communicable Diseases | 3 | 2021 | 875 | 0.230 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2013 | 2151 | 0.210 |
Why?
|
| Schistosoma mansoni | 4 | 2023 | 155 | 0.190 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2021 | 98 | 0.180 |
Why?
|
| Rural Population | 3 | 2021 | 2285 | 0.180 |
Why?
|
| Helminth Proteins | 1 | 2021 | 173 | 0.170 |
Why?
|
| Fucose | 1 | 2020 | 122 | 0.170 |
Why?
|
| Insect Proteins | 1 | 2021 | 254 | 0.170 |
Why?
|
| Urbanization | 1 | 2019 | 100 | 0.160 |
Why?
|
| Child, Preschool | 10 | 2021 | 42230 | 0.150 |
Why?
|
| Pregnancy | 15 | 2017 | 29874 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2023 | 22176 | 0.140 |
Why?
|
| Double-Blind Method | 8 | 2017 | 12341 | 0.130 |
Why?
|
| Africa | 1 | 2018 | 709 | 0.130 |
Why?
|
| Parents | 2 | 2020 | 3563 | 0.130 |
Why?
|
| Risk Factors | 8 | 2021 | 74206 | 0.120 |
Why?
|
| Infectious Disease Transmission, Vertical | 3 | 2013 | 1351 | 0.120 |
Why?
|
| Educational Status | 2 | 2019 | 2522 | 0.110 |
Why?
|
| Prevalence | 7 | 2021 | 15732 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2018 | 1060 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2014 | 141 | 0.110 |
Why?
|
| Rhinitis | 1 | 2020 | 747 | 0.100 |
Why?
|
| Malaria | 3 | 2013 | 1227 | 0.100 |
Why?
|
| Histamine | 1 | 2014 | 499 | 0.100 |
Why?
|
| Immune System Diseases | 1 | 2014 | 256 | 0.100 |
Why?
|
| Pneumonia | 1 | 2023 | 2143 | 0.090 |
Why?
|
| Respiratory Sounds | 2 | 2017 | 702 | 0.090 |
Why?
|
| Growth | 1 | 2013 | 365 | 0.090 |
Why?
|
| Adolescent | 10 | 2021 | 88319 | 0.090 |
Why?
|
| Child | 10 | 2021 | 80153 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2021 | 4544 | 0.090 |
Why?
|
| Infant | 11 | 2021 | 36192 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 683 | 0.090 |
Why?
|
| Female | 23 | 2021 | 392644 | 0.080 |
Why?
|
| Infant, Newborn | 7 | 2021 | 26198 | 0.080 |
Why?
|
| HIV Infections | 4 | 2013 | 17351 | 0.080 |
Why?
|
| Antibodies, Helminth | 1 | 2009 | 57 | 0.080 |
Why?
|
| Antigens, Helminth | 1 | 2009 | 68 | 0.080 |
Why?
|
| Comorbidity | 2 | 2020 | 10508 | 0.080 |
Why?
|
| Humans | 30 | 2023 | 761504 | 0.080 |
Why?
|
| Vaccines | 1 | 2017 | 844 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2013 | 655 | 0.070 |
Why?
|
| Life Style | 1 | 2019 | 3917 | 0.070 |
Why?
|
| Incidence | 4 | 2014 | 21353 | 0.070 |
Why?
|
| Congenital Abnormalities | 1 | 2011 | 709 | 0.070 |
Why?
|
| Anonymous Testing | 1 | 2005 | 9 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1459 | 0.060 |
Why?
|
| Vaginal Diseases | 1 | 2006 | 103 | 0.060 |
Why?
|
| HIV Seroprevalence | 1 | 2005 | 89 | 0.060 |
Why?
|
| Poverty | 1 | 2017 | 2698 | 0.060 |
Why?
|
| Male | 13 | 2021 | 360804 | 0.060 |
Why?
|
| AIDS Serodiagnosis | 1 | 2005 | 220 | 0.060 |
Why?
|
| New Zealand | 1 | 2023 | 358 | 0.050 |
Why?
|
| Population Surveillance | 2 | 2019 | 2598 | 0.050 |
Why?
|
| National Health Programs | 1 | 2005 | 440 | 0.050 |
Why?
|
| Anemia | 2 | 2011 | 1509 | 0.050 |
Why?
|
| Blattellidae | 1 | 2021 | 3 | 0.050 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2006 | 662 | 0.040 |
Why?
|
| Animals | 8 | 2023 | 168459 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12463 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2005 | 1038 | 0.040 |
Why?
|
| Brazil | 1 | 2023 | 1230 | 0.040 |
Why?
|
| Perception | 1 | 2005 | 1197 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2006 | 1139 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 817 | 0.040 |
Why?
|
| Carbohydrates | 1 | 2020 | 390 | 0.040 |
Why?
|
| Adult | 10 | 2019 | 221177 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2019 | 64680 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2017 | 41487 | 0.040 |
Why?
|
| Counseling | 1 | 2005 | 1547 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2008 | 7827 | 0.040 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 300 | 0.030 |
Why?
|
| Immunization | 1 | 2019 | 1228 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2017 | 744 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2019 | 1004 | 0.030 |
Why?
|
| Young Adult | 4 | 2019 | 59243 | 0.030 |
Why?
|
| Epitopes | 1 | 2020 | 2503 | 0.030 |
Why?
|
| Morbidity | 1 | 2019 | 1750 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2007 | 2947 | 0.030 |
Why?
|
| Weaning | 1 | 2013 | 103 | 0.030 |
Why?
|
| Wasting Syndrome | 1 | 2013 | 99 | 0.030 |
Why?
|
| Ancylostomatoidea | 1 | 2011 | 5 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2023 | 2747 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 3205 | 0.020 |
Why?
|
| Age Factors | 2 | 2021 | 18395 | 0.020 |
Why?
|
| Perinatal Mortality | 1 | 2011 | 101 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 26125 | 0.020 |
Why?
|
| Parasite Egg Count | 1 | 2009 | 29 | 0.020 |
Why?
|
| Thinness | 1 | 2013 | 490 | 0.020 |
Why?
|
| Vaccination | 2 | 2012 | 3384 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 23995 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 10209 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2013 | 870 | 0.020 |
Why?
|
| Cytokines | 1 | 2023 | 7396 | 0.020 |
Why?
|
| HIV-1 | 1 | 2005 | 6863 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1570 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2019 | 9646 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2011 | 858 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39106 | 0.020 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2007 | 179 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16591 | 0.020 |
Why?
|
| Developing Countries | 1 | 2017 | 2885 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 2005 | 504 | 0.010 |
Why?
|
| Birth Weight | 1 | 2011 | 2103 | 0.010 |
Why?
|
| Mothers | 1 | 2013 | 2198 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2007 | 1525 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2011 | 2921 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 2645 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3267 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10766 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81525 | 0.010 |
Why?
|
| Risk | 1 | 2005 | 9610 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14666 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15500 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 220895 | 0.000 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_